Key takeaways
Ceftaroline (Teflaro) and ceftibuten (formerly Cedax) are both cephalosporin antibiotics used to treat bacterial infections. They share a similar mechanism of action by preventing bacteria from forming a protective covering, but they differ in several key aspects. Ceftaroline is a fifth-generation cephalosporin administered via intravenous infusion and is FDA-approved for treating pneumonia and bacterial skin infections, including those caused by resistant bacteria like MRSA. In contrast, ceftibuten was a third-generation cephalosporin available in oral form, used for treating infections like bronchitis, otitis media, and strep throat, but it has been discontinued in the U.S. Ceftaroline is available only as a brand-name medication, while ceftibuten, including its generic form, is no longer available. Ceftaroline's side effects include diarrhea, nausea, and rash, with potential serious reactions like nervous system effects and allergic reactions, especially in those with penicillin allergies. Ceftaroline does not interact with other medications, whereas ceftibuten's interaction profile is not detailed due to its discontinuation.
